Control Of Gastrointestinal Motility By Interstitial Cells And Neuronal Projections
Funder
National Health and Medical Research Council
Funding Amount
$845,540.00
Summary
The gastrointestinal tract moves contents along its length in an ordered manner, so allowing digestion and absorption of gut contents. These movements are controlled by the properties of the cells in the muscle layers which in part make up the wall of the gastrointestinal tract, by activity in the nerves that innervate the gut and by hormonal factors. Recently we have shown that a key part of the control system lies in a set of special cells, interstitial cells, that lie amongst the muscle cells ....The gastrointestinal tract moves contents along its length in an ordered manner, so allowing digestion and absorption of gut contents. These movements are controlled by the properties of the cells in the muscle layers which in part make up the wall of the gastrointestinal tract, by activity in the nerves that innervate the gut and by hormonal factors. Recently we have shown that a key part of the control system lies in a set of special cells, interstitial cells, that lie amongst the muscle cells. This project will determine how these cells exert their control. These cells generate large long lasting waves of voltage which flow to nearby muscle cells so causing them to contract. The first aim is to determine how the special cells generate the command signals and the second aim is to determine how the signals spread to the muscle cells. The subsequent section of the project will determine how the behavior of the cells in the gastrointestinal tract are controlled by nervous influences. Disorders of the intestine are frequent and these appear to involve disrupted muscle contraction either because the intrinsic control system is malfunctioning or because the nervous system is unable to exert its normal influence. This project will determine how the normal control system works, invariably when this has been done with other systems, disease states are easier to rectify.Read moreRead less
Combination Methotrexate And Gefitinib To Cure Ectopic Pregnancies: Phase I-II Clinical Trials
Funder
National Health and Medical Research Council
Funding Amount
$235,875.00
Summary
Ectopic pregnancies are dangerous emergencies that can cause fatal bleeding. Most require surgery. We plan to test a novel medication-based treatment that could be used to cure most ectopics. If successful, it could revolutionise current management.
Heart rhythm devices have revolutionised the survival of patients with heart disease. However we still do not know precisely what the outcomes are in patients attending our local hospitals. We will develop a registry for these devices to monitor and benchmark their performance throughout the state. The development of a registry enables us to assess the quality of health services at a local level. This project has the potential to improve the health outcomes of 4 million people with heart disease
Translating New Therapeutics And Diagnostics For Major Pregnancy Complications
Funder
National Health and Medical Research Council
Funding Amount
$481,156.00
Summary
My research is focussed on tackling major complications of pregnancy that are a threat to the lives of both mother’s and babies. We are developing new drug treatments for ectopic pregnancy (a dangerous condition where the pregnancy implants in the Fallopian tube), and preeclampsia (a condition where toxins leak out of the placenta into mum's blood, and can seriously injure many of mum's major organs). We are also generating a blood test that may help women avoid the tragedy of a stillbirth.
Development Of Vinorelbine As A Tablet Based Therapy To Cure Ectopic Pregnancies
Funder
National Health and Medical Research Council
Funding Amount
$361,594.00
Summary
Ectopic pregnancies occur if the pregnancy implants in the Fallopian tube. They can be deadly and most are treated surgically. We will examine the exciting possibility that instead of surgery, ectopic pregnancies may be cured with a tablet taken just once. We will perform laboratory studies and a clinical trial, giving vinorelbine to women with ectopic pregnancies.
Development Of Novel Medical Therapies To Cure Ectopic Pregnancies
Funder
National Health and Medical Research Council
Funding Amount
$601,156.00
Summary
Ectopic pregnancies are conceptions implanting outside the womb, mainly the fallopian tube. They are pathological, and can erode straight through the tube into large blood vessels causing fatal bleeding and death. We plan to assess three medication based approaches to treat this condition that would avoid surgery entirely. If we succeed, and subsequently translate one or more of these treatments to the clinic, it would revolutionise management of this serious gynaecological emergency.
Heartbeats are considered to arise through specialised pacemaker cells establishing rhythmically generated (i.e. pacemaker) action potentials, which then trigger propagating action potentials in heart muscle causing contraction and pumping of blood. This research proposal aims to challenge the physical model that is used to describe this pacemaker process and resultant heart conduction. Our reasons for doing this derive from our discovery of an alternative pacemaker-conduction mechanism, which w ....Heartbeats are considered to arise through specialised pacemaker cells establishing rhythmically generated (i.e. pacemaker) action potentials, which then trigger propagating action potentials in heart muscle causing contraction and pumping of blood. This research proposal aims to challenge the physical model that is used to describe this pacemaker process and resultant heart conduction. Our reasons for doing this derive from our discovery of an alternative pacemaker-conduction mechanism, which we have shown to operate in various smooth muscles. This mechanism, termed store-based pacemaking, is entirely different to the currently held cardiac model but could readily achieve the same outcome. We will investigate the hypothesis that this pacemaker mechanism is also fundamental to heart pacemaking and conduction. Positive support for our hypothesis, as indicated by our pilot findings, may severely challenge the present model for cardiac pacemaking. Such an outcome will have major ramifications on present interpretation of cardiac function in health and disease and will be particularly important to interpretation of disorders associated with cardiac arrhythmias and heart conduction.Read moreRead less
Developing New Therapeutic Strategies For Brain Cancer
Funder
National Health and Medical Research Council
Funding Amount
$763,845.00
Summary
Each year, over 1,500 Australians will develop brain cancer. Unlike many cancers, it cannot be prevented by lifestyle changes. Adults with brain cancer usually die within 2 years. The overall aims of this funding are to extend patients' lives and build brain cancer research in Australia so that we have the best chance of curing this disease. The expected outcome is clinical trial of drug candidates for the most common and most deadly brain cancer, high-grade glioma.